ALEXANDRIA, Va., Nov. 3 -- United States Patent no. RE51,105, issued on Nov. 3, was assigned to UBE Corp. (Ube, Japan).
"Medical composition for treatment or prophylaxis of glaucoma" was invented by Masahiko Hagihara (Ube, Japan), Kenji Yoneda (Ube, Japan), Eiji Okanari (Ube, Japan) and Manabu Shigetomi (Ube, Japan).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is to provide a medical composition for the treatment or prophylaxis of glaucoma which comprises a pyridylaminoacetic acid compound represented by the formula (1):wherein R1, R2, R3, Y, and Z are defined in the specification."
The patent was filed on Feb. 14, 2024, under Application No. 18/442,047.
*For further information, inc...